CLOV
Clover Health Investments, Corp.
NASDAQ · USHealthcareMedical - Healthcare Plans
$4.50-2.60%
Price as of Jul 20, 2026
CLOV profitability
Clover Health Investments, Corp. profitability
Margins, returns on capital and operating-efficiency metrics from the latest trailing period.
Margins
- Gross margin
- 18.4%
- EBITDA margin
- -2.5%
- EBIT margin
- -2.6%
- Net margin
- -2.6%
- Free cash flow margin
- 2.5%
Returns
- Return on equity
- -16.8%
- Return on assets
- -8.2%
- Return on invested capital
- -16.8%
- Asset turnover
- 3.57x
Cash efficiency
- Cash from operations
- $57.3M
- Cash per share
- $0.34
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.